Search

everythinglearnresearchcommunity

for

Search:↓

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

STAT5 activation is crucial for starting the hair growth phase.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Both human and animal-derived small extracellular vesicles speed up skin healing equally well.

Combining light therapy and microneedling shows promise for treating female hair loss.

Human hair protein modifications could potentially indicate heart disease risk.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Collagen membranes improve melanocyte growth for treating skin depigmentation.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Future hair loss treatments focus on non-invasive and regenerative methods, needing more clinical trials.

Standardized protocols are crucial for effective use of platelet-rich plasma and fibrin in tissue regeneration.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

Cats with abnormal hair had DSG4 gene changes causing hair problems.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Noggin is necessary to start the hair growth phase in skin after birth.

The dermal papilla is crucial for hair growth and health, and understanding it could lead to new hair loss treatments.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.